IP Library Granted Patent US 11,768,167
Granted Patent B2
US 11,768,167 · App. 17/094,473 · Granted Sep 26, 2023

Ferrocene labels for electrochemical assay and their use in analytical methods

Inventors: Barrie Marsh (Trowbridge, GB); Jonathan Sharp (Bath And Northeast Somerset, GB); Stephen Flower (Melksham, GB); Christopher Frost (Bath And Northeast Somerset, GB)
G01N27/3276C07F17/02C12Q1/6816
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,768,167
App. No.
17/094,473
Granted
Sep 26, 2023
Kind
B2
Abstract

Compounds of general formula I are used as labels in an electrochemical assay: (I) in which: Fc and Fc′ are substituted or unsubstituted ferrocenyl moieties, X is a C1 to C6 alkylene chain which is optionally interrupted by —O— or —NH—; Y is a C1 to C6 alkylene chain which is optionally interrupted by —O— or —NH—; Z is a C1 to C12 alkylene chain which may optionally be substituted and/or may optionally be interrupted by —O—, —S—, cycloalkyl, —CO—, —CONR1-, —NR1CO— or —NR1- in which R1 represents hydrogen or C1 to C4 alkyl; and R is a linker group. Compounds I are used to make labelled substrates, as well as functionalised compounds for making the labelled substrates.

Claims (4)

1. A method of detecting a nucleic acid, the method comprising:

contacting the nucleic acid with a complementary nucleic acid probe under conditions to allow hybridization between said probe and an amplicon; and

selectively degrading the probe, wherein the probe is labelled with the compound:

2. The method of claim 1 , further comprising measuring electrochemical activity of the compound labelling the probe, wherein said electrochemical activity is dependent either quantitatively or qualitatively on the degradation of the probe.

Assignments (6)
SECURITY INTEREST Recorded Mar 25, 2025
From: BINX HEALTH LIMITED
To: KREOS CAPITAL VII (UK) LIMITED
Reel/Frame 070620/0287 →
RELEASE OF SECURITY INTEREST Recorded Jan 18, 2025
From: BX HEP AGGREGATOR, LLC,
To: BINX HEALTH LIMITED
Reel/Frame 069925/0466 →
ASSIGNMENT OF PATENT SECURITY AGREEMENT Recorded Oct 3, 2024
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: BX HEP AGGREGATOR, LLC
Reel/Frame 069107/0116 →
PATENT SECURITY AGREEMENT Recorded Apr 7, 2021
From: BINX HEALTH LIMITED
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 055859/0724 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2021
From: MARSH, BARRIE; SHARP, JONATHAN; FLOWER, STEPHEN; FROST, CHRISTOPHER
To: ATLAS GENETICS LIMITED
Reel/Frame 054969/0366 →
CHANGE OF NAME Recorded Jan 20, 2021
From: ATLAS GENETICS LIMITED
To: BINX HEALTH LIMITED
Reel/Frame 054969/0496 →
Priority Claims (1)
GB 1021896 · Dec 22, 2010 · national
Continuity (4)
Division 16666750 · Oct 29, 2019
Continuation 15908133 · Feb 28, 2018
Continuation 13996748
Related Publication 20210116409A1 · Apr 22, 2021
Cited By (1)
US 12,601,703